- Home
- FOLD vs XMTR Comparison
FOLD vs XMTR Comparison
Compare FOLD & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- XMTR
- Stock Information
- Founded
- FOLD 2002
- XMTR 2013
- Country
- FOLD United States
- XMTR United States
- Employees
- FOLD N/A
- XMTR N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- XMTR Industrial Machinery/Components
- Sector
- FOLD Health Care
- XMTR Technology
- Exchange
- FOLD Nasdaq
- XMTR Nasdaq
- Market Cap
- FOLD 2.5B
- XMTR 2.7B
- IPO Year
- FOLD 2007
- XMTR 2021
- Fundamental
- Price
- FOLD $8.15
- XMTR $53.25
- Analyst Decision
- FOLD Strong Buy
- XMTR Buy
- Analyst Count
- FOLD 9
- XMTR 11
- Target Price
- FOLD $26.44
- XMTR $37.00
- AVG Volume (30 Days)
- FOLD 5.8M
- XMTR 753.3K
- Earning Date
- FOLD 11-05-2025
- XMTR 11-04-2025
- Dividend Yield
- FOLD N/A
- XMTR N/A
- EPS Growth
- FOLD N/A
- XMTR N/A
- EPS
- FOLD N/A
- XMTR N/A
- Revenue
- FOLD $571,160,000.00
- XMTR $603,762,000.00
- Revenue This Year
- FOLD $20.98
- XMTR $22.96
- Revenue Next Year
- FOLD $20.74
- XMTR $17.80
- P/E Ratio
- FOLD N/A
- XMTR N/A
- Revenue Growth
- FOLD 25.35
- XMTR 20.19
- 52 Week Low
- FOLD $5.51
- XMTR $16.26
- 52 Week High
- FOLD $12.65
- XMTR $58.03
- Technical
- Relative Strength Index (RSI)
- FOLD 56.40
- XMTR 56.64
- Support Level
- FOLD $7.69
- XMTR $48.82
- Resistance Level
- FOLD $8.59
- XMTR $57.87
- Average True Range (ATR)
- FOLD 0.37
- XMTR 2.51
- MACD
- FOLD -0.05
- XMTR -0.66
- Stochastic Oscillator
- FOLD 54.44
- XMTR 45.18
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.